Stigma and substance use disorders: An international phenomenon

Current Opinion in Psychiatry

Volumn 30, Issue 5, 2017, Pages 378-388

  Yang, Lawrence H ^a,b   Wong, Liang Y ^c   Grivel, Margaux M ^c   Hasin, Deborah S ^b,d,e  

^a NEW YORK UNIVERSITY   (United States)

^b Department of Medicine   (United States)

^c Columbia University ^*  (United States)

^d Columbia University College of Physicians and Sur ^*  (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

discrimination; drug abuse; stigma; substance use disorder

Indexed keywords

ALCOHOL; CANNABIS; DIAMORPHINE;

ALCOHOL ABUSE; BEHAVIOR; CANNABIS ADDICTION; DECISION MAKING; DRUG DEPENDENCE; EMOTION; HAZARD; HEROIN DEPENDENCE; HUMAN; INFORMATION RETRIEVAL; MEDLINE; MORALITY; NEGATIVE EMOTIONAL REACTION; PERSUASIVE COMMUNICATION; PREVALENCE; PROGNOSIS; PSYCINFO; REVIEW; SOCIAL DISCRIMINATION; SOCIAL DISTANCE; STEREOTYPING; STIGMA; UNITED STATES; UNPREDICTABILITY; WEB OF SCIENCE; PSYCHOLOGY; SOCIAL STIGMA;

HUMANS; PREVALENCE; SOCIAL STIGMA; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 85023195369     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0000000000000351     Document Type: Review

References (35)

1. Saha TD, Kerridge BT, Goldstein RB, et al. Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States. J Clin Psychiatry 2016; 77:772-780.
2. Hasin DS, Kerridge BT, Saha TD, et al. Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry 2016; 173:588-599.
3. Grant BF, Saha TD, Ruan WJ, et al. Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry 2016; 73:39-47.
4. Grant BF, Goldstein RB, Saha TD, et al. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry 2015; 72:757-766.
5. NIDA. National Institute on Drug Abuse 2016-2020 Strategic Plan. In: Strategic Plan. Edited by: National Institite on Drug Abuse. 2016. p. 1-63
6. Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc Sci Med 2010; 71:2150-2161.
7. Crisp A, Gelder M, Goddard E, Meltzer H. Stigmatization of people with mental illnesses: a follow-up study within the changing minds campaign of the Royal College of Psychiatrists. World Psychiatry 2005; 4:106-113.
8. Link BG, Phelan JC, Bresnahan M, et al. Public conceptions of mental illness: labels, causes, dangerousness, and social distance. Am J Public Health 1999; 89:1328-1333.
9. Pescosolido BA, Monahan J, Link BG, et al. The public's view of the competence, dangerousness, and need for legal coercion of persons with mental health problems. Am J Public Health 1999; 89:1339-1345.
10. Schomerus G, Lucht M, Holzinger A, et al. The stigma of alcohol dependence compared with other mental disorders: a review of population studies. Alcohol Alcohol 2011; 46:105-112.
11. Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry 2015; 72:1235-1242.
12. Corrigan PW, Kuwabara SA, O'Shaughnessy J. The public stigma of mental illness and drug addiction: findings from a stratified random sample. J Soc Work (Lond) 2009; 9:139-147.
13. Semple SJ, Grant I, Patterson TL. Utilization of drug treatment programs by methamphetamine users: the role of social stigma. Am J Addict 2005; 14:367-380.
14. Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol 2001; 27:363-385.
15. Mannarini S, Boffo M. Anxiety, bulimia, drug and alcohol addiction, depression, and schizophrenia: what do you think about their aetiology, dangerousness, social distance, and treatment? A latent class analysis approach. Soc Psychiatry Psychiatr Epidemiol 2015; 50:27-37.
16. Crisp AH, Gelder MG, Rix S, et al. Stigmatisation of people with mental illnesses. Br J Psychiatry 2000; 177:4-7.
17. Hengartner MP, Loch AA, Lawson FL, et al. Public stigmatization of different mental disorders: a comprehensive attitude survey. Epidemiol Psychiatr Sci 2013; 22:269-274.
18. Mushtaq S, Mendes V, Nikolaou V, Luty J. Analysis of the possible components of stigmatised attitudes towards depression and heroin dependence. J Subst Use 2015; 20:399-406.
19. van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Public opinion on imposing restrictions to people with an alcohol or drug addiction: a crosssectional survey. Soc Psychiatry Psychiatr Epidemiol 2013; 48:2007-2016.
20. Sorsdahl K, Stein DJ, Myers B. Negative attributions towards people with substance use disorders in South Africa: variation across substances and by gender. BMC Psychiatry 2012; 12:101.
21. Sorsdahl KR, Stein DJ. Knowledge of and stigma associated with mental disorders in a South african community sample. J Nerv Ment Dis 2010; 198:742-747.
22. Marie D, Miles B. Social distance and perceived dangerousness across four diagnostic categories of mental disorder. Aust N Z J Psychiatry 2008; 42:126-133.
23. Crespo M, Perez-Santos E, Munoz M, Guillen AI. Descriptive study of stigma associated with severe and persistent mental illness among the general population of Madrid (Spain). Community Ment Health J 2008; 44:393-403.
24. Koski-Jannes A, Hirschovits-Gerz T, Pennonen M. Population, professional, and client support for different models of managing addictive behaviors. Subst Use Misuse 2012; 47:296-308.
25. Thege BK, Colman I, El-Guebaly N, et al. Social judgments of behavioral versus substance-related addictions: a population-based study. Addict Behav 2015; 42:24-31.
26. Herek GM, Capitanio JP, Widaman KF. Stigma, social risk, and health policy: public attitudes toward HIV surveillance policies and the social construction of illness. Health Psychol 2003; 22:533-540.
27. Capitanio JP, Herek GM. AIDS-related stigma and attitudes toward injecting drug users among Black and White Americans. Am Behav Sci 1999; 42:1148-1161.
28. Carliner H, Delker E, Fink DS, et al. Racial discrimination, socioeconomic position, and illicit drug use among US Blacks. Soc Psychiatry Psychiatr Epidemiol 2016; 51:551-560.
29. Yankah EN. When addiction has a White face. The New York Times, February 6, 2016 edition; A23.
30. Martins SS, Sarvet A, Santaella-Tenorio J, et al. Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry 2017; 74:445-455.
31. van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Tijdschr Psychiatr 2015; 57:489-497.
32. Crapanzano K, Vath RJ, Fisher D. Reducing stigma towards substance users through an educational intervention: harder than it looks. Acad Psychiatry 2014; 38:420-425.
33. van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Healthcare professionals' regard towards working with patients with substance use disorders: comparison of primary care, general psychiatry and specialist addiction services. Drug Alcohol Depend 2014; 134:92-98.
34. Martins SS, Segura LE, Santaella-Tenorio J, et al. Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014. Addict Behav 2017; 65:236-241.
35. Compton WM, Han B, Jones CM, et al. Marijuana use and use disorders in adults in the USA, 2002-1414: analysis of annual cross-sectional surveys. Lancet Psychiatry 2016; 3:954-964.